| P50 | author | Sally A Shumaker | Q114424439 |
| P2093 | author name string | Dugan E | |
| | Dailey ME | |
| | McBee WL | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| | Influence of education and occupation on the incidence of Alzheimer's disease | Q28251102 |
| | Education and the prevalence of dementia and Alzheimer's disease | Q29037629 |
| | 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro | Q34289335 |
| | Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism | Q34327930 |
| | Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain | Q37022564 |
| | Epidemiology of multi-infarct dementia | Q37769247 |
| | The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease | Q39605803 |
| | The prevalence of dementia: a quantitative integration of the literature | Q39692741 |
| | The role of free radicals in disease. | Q40449745 |
| | Senile dementia-Alzheimer's type and estrogen | Q40525885 |
| | Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women | Q40557218 |
| | Neuroimmune mechanisms in Alzheimer disease pathogenesis | Q40647382 |
| | Mechanisms of estrogen action during neural development: mediation by interactions with the neurotrophins and their receptors? | Q40971168 |
| | Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies | Q41075378 |
| | A case-control study of Alzheimer's disease in China | Q41128795 |
| | A case-control study of Alzheimer's disease in Australia | Q41198222 |
| | A case-control study of Alzheimer's disease | Q41220542 |
| | Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats | Q42436381 |
| | Senile dementia of the Alzheimer type | Q42447051 |
| | Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats | Q42491843 |
| | Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study | Q42633058 |
| | Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills | Q43919019 |
| | Estrogen replacement therapy and memory in older women | Q44222186 |
| | Women, myocardial infarction, and dementia in the very old. | Q44824278 |
| | Estrogen replacement therapy and cognitive function in older women | Q44924133 |
| | Estrogen deficiency and risk of Alzheimer's disease in women. | Q45935585 |
| | Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects | Q46604770 |
| | Sex differences in postischemic neuronal necrosis in gerbils | Q46697696 |
| | Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. | Q48124413 |
| | Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type | Q48395222 |
| | A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group | Q48418557 |
| | Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. | Q48459426 |
| | Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. | Q50613976 |
| | Relative Rates of Dementia By Multiple Case Definitions, Over Two Prevalence Periods, In Three Sociocultural Groups. | Q52019205 |
| | Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. | Q52020137 |
| | Aphasia in dementia of the Alzheimer type. | Q52089788 |
| | Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. | Q52112673 |
| | Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. | Q52127221 |
| | Effects of estrogen on memory function in surgically menopausal women | Q52229708 |
| | Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. | Q52884779 |
| | Anti-inflammatory drugs and Alzheimer disease. | Q53183421 |
| | Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. | Q53210407 |
| | Rheumatoid arthritis and susceptibility to Alzheimer's disease. | Q53294858 |
| | Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study | Q53295392 |
| | Alzheimer's disease and rheumatoid arthritis. | Q53316929 |
| | Clinical trial of indomethacin in Alzheimer's disease. | Q53318286 |
| | More evidence links NSAID, estrogen use with reduced Alzheimer risk. | Q53320288 |
| | Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study | Q57782164 |
| | Low Body Mass Index in demented outpatients | Q68011677 |
| | Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils | Q68126704 |
| | Diagnosis of Alzheimer's disease | Q69871134 |
| | Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort | Q70534213 |
| | Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type | Q70803658 |
| | Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease | Q71123711 |
| | Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones | Q71388080 |
| | Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons | Q71464474 |
| | Down's syndrome: Prophylaxis and therapy for the frequently comorbid Alzheimer's disease | Q72039647 |
| | Hip fracture | Q72532425 |
| | The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada | Q72829553 |
| P433 | issue | 2 | |
| P921 | main subject | Hormone Replacement Therapy | Q108667313 |
| P304 | page(s) | 329-345 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | Hormone replacement therapy and other potential treatments for dementias | |
| P478 | volume | 26 | |